- Home
- LCNB vs INBX Comparison
LCNB vs INBX Comparison
Compare LCNB & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- INBX
- Stock Information
- Founded
- LCNB 1877
- INBX 2010
- Country
- LCNB United States
- INBX United States
- Employees
- LCNB N/A
- INBX N/A
- Industry
- LCNB Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- LCNB Finance
- INBX Health Care
- Exchange
- LCNB Nasdaq
- INBX Nasdaq
- Market Cap
- LCNB 212.3M
- INBX 222.5M
- IPO Year
- LCNB N/A
- INBX 2020
- Fundamental
- Price
- LCNB $16.89
- INBX $13.98
- Analyst Decision
- LCNB
- INBX Hold
- Analyst Count
- LCNB 0
- INBX 1
- Target Price
- LCNB N/A
- INBX N/A
- AVG Volume (30 Days)
- LCNB 22.3K
- INBX 70.4K
- Earning Date
- LCNB 10-21-2024
- INBX 11-14-2024
- Dividend Yield
- LCNB 5.13%
- INBX N/A
- EPS Growth
- LCNB N/A
- INBX N/A
- EPS
- LCNB 0.52
- INBX 119.38
- Revenue
- LCNB $74,686,000.00
- INBX $1,568,000.00
- Revenue This Year
- LCNB N/A
- INBX N/A
- Revenue Next Year
- LCNB $15.49
- INBX N/A
- P/E Ratio
- LCNB $32.96
- INBX $0.12
- Revenue Growth
- LCNB 3.03
- INBX 19.24
- 52 Week Low
- LCNB $12.42
- INBX $10.80
- 52 Week High
- LCNB $17.27
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- LCNB 62.34
- INBX 37.51
- Support Level
- LCNB $16.56
- INBX $13.27
- Resistance Level
- LCNB $17.04
- INBX $14.49
- Average True Range (ATR)
- LCNB 0.34
- INBX 1.00
- MACD
- LCNB -0.01
- INBX -0.23
- Stochastic Oscillator
- LCNB 71.21
- INBX 33.53
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.